Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 7
2003 6
2004 3
2005 5
2006 9
2007 8
2008 9
2009 7
2010 7
2011 5
2012 5
2013 6
2014 9
2015 2
2016 4
2017 8
2018 4
2019 3
2020 8
2021 3
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 33288629

101 results
Results by year
Filters applied: . Clear all
Page 1
A randomized controlled trial of darbepoetin alfa administered as a fixed or weight-based dose using a front-loading schedule in patients with anemia who have nonmyeloid malignancies.
Hesketh PJ, Arena F, Patel D, Austin M, D'Avirro P, Rossi G, Colowick A, Schwartzberg L, Bertoli LF, Cole JT, Demetri G, Dessypris E, Dobbs T, Eisenberg P, Fleischman R, Hall J, Hoffman PC, Laber DA, Leonard J, Lester EP, McCachren S, McMeekin S, Meza L, Miller DS, Nand S, Oliff I, Paroly W, Pawl L, Perez A, Raftopoulos H, Rigas J, Rowland K, Scullin DC Jr, Tezcan H, Waples J, Ward J, Yee LK. Hesketh PJ, et al. Cancer. 2004 Feb 15;100(4):859-68. doi: 10.1002/cncr.11954. Cancer. 2004. PMID: 14770445 Free article. Clinical Trial.
Darbepoetin alfa for treating chemotherapy-induced anemia in patients with a baseline hemoglobin level < 10 g/dL versus > or = 10 g/dL: an exploratory analysis from a randomized, double-blind, active-controlled trial.
Vansteenkiste J, Hedenus M, Gascon P, Bokemeyer C, Ludwig H, Vermorken J, Hamilton L, Bridges K, Pujol B. Vansteenkiste J, et al. BMC Cancer. 2009 Sep 3;9:311. doi: 10.1186/1471-2407-9-311. BMC Cancer. 2009. PMID: 19728887 Free PMC article. Clinical Trial.
101 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page